Stylianos Mandanas

Treatment compliance and severe adverse events limit the use of tyrosine kinase inhibitors in refractory thyroid cancer

Kalliopi Pazaitou‐Panayiotou, Alexandra Chrisoulidou, Stylianos Mandanas et al. · OncoTargets and Therapy · 2015 · 32 citations · Full text

Predictive factors that influence the course of medullary thyroid carcinoma

Kalliopi Pazaitou‐Panayiotou, Alexandra Chrisoulidou, Stylianos Mandanas et al. · International Journal of Clinical Oncology · 2013 · 28 citations

Predictive Factors, Medicine, Thyroid Disease +7

Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment

Elena Tsourdi, Polyzois Makras, Tilman D. Rachner et al. · Bone · 2018 · 28 citations

Bone Disease, Bone Health, Gynecology +9

Breast Metastasis from Medullary Thyroid Carcinoma in a Male Patient: Case Report and Review of the Literature

Stylianos Mandanas, Efterpi Margaritidou, Varvara Christoforidou et al. · Rare Tumors · 2015 · 18 citations · Full text

Breast Oncology, Health Sciences, Breast Metastasis +11

Parathyroid involvement in thyroid cancer: an unforeseen event

Alexandra Chrisoulidou, Stylianos Mandanas, Periklis Mitsakis et al. · World Journal of Surgical Oncology · 2012 · 18 citations · Full text